The drug-related AIDS epidemic in Connecticut

Health emergency

Through the end of 1998, some 6,200 Connecticut residents age 13 and over had injection-related AIDS or had died from it. (1)

Connecticut has the fourth highest injection-related AIDS rate in the nation. (2)

More than three-quarters of all AIDS cases in Connecticut are injection-related. (3)

Metro areas ranking among highest in the U.S.

The Hartford metro area ranks sixth in injection-related AIDS among U.S. metro areas of over 500,000.  (The Hartford metro area is tied for sixth with the Baton Rouge, Louisiana, metro area.)

The New Haven-Bridgeport metro area ranks tenth. (4)

The crisis among African Americans and Latinos

Through the end of 1998, some 2,900 African Americans and 1,800 Latinos living in Connecticut had injection-related AIDS or had died from it.

The rate of injection-related AIDS cases among blacks in Connecticut is 19 times higher than the rate for whites.  The rate for Latinos is 15 times higher than the rate for whites. (5)

Thousands of all races at risk

In 1996, in the Hartford and New Haven metropolitan areas, there were an estimated 58,000 who were at risk for HIV either because they injected drugs or because they were the heterosexual partners of persons who injected drugs. (6)

Information on the USA and other states

_________________
Footnotes  

(1)

AIDS data are from a special tabulation from the Centers for Disease Control.  Injection-related AIDS cases include persons in the following risk groups: persons who inject drugs; men who have sex with men and inject drugs; and the heterosexual partners of persons who inject drugs.  AIDS cases are rounded to the nearest hundred.  

(2)

Injection-related AIDS rates per million for states were calculated using injection-related AIDS cases among persons age 13 and over (the 3-year average for the years 1996-1998) divided by the 1997 population age 13 and over.  The 3-year average was used to smooth out any unusual variations from year to year and to get a more realistic final figure. When ties occurred in state rates, the states involved were given the same rank.

U.S. population data are from the U.S. Bureau of Census.  The population of Puerto Rico age 13 and over was estimated using total population data from the U.S. Bureau of the Census and the projected age distributions from Eduard Bos, My T. Vu, Ernest Massiah, and Rodolfo A. Bulatao, World population projections 1994-1995.  Baltimore: Johns Hopkins Press, 1994, page 410.  

(3)

The percentage of AIDS cases that are injection-related was calculated by dividing the number of injection-related AIDS cases (the 3-year average from the years 1996-1998) by the number of AIDS cases for which the exposure group is known (also a 3-year average from the years 1996-1998).  Each percent is rounded to the nearest 5.  Thus, for example, 42 percent was rounded to 40.

(4)

Injection-related AIDS rates per million for metro areas were calculated using injection-related AIDS cases among persons age 13 and over (the 3-year average for the years 1996-1998) divided by the total 1997 population (including those age 12 and under). Population data are from the U.S. Bureau of Census.  When ties occurred in rates, the metro areas involved were given the same rank.  

(5)

Injection-related AIDS rates per million by race/ethnic group for each state were calculated using injection-related AIDS cases among persons age 13 and over for each racial/ethnic group (the 3-year average for the years 1996-1998) divided by the 1997 population  age 13 and over for that racial/ethnic group.  In instances when the ratio of AIDS rates for African Americans to whites or Latinos to whites was greater than 20, the ratio is reported as "greater than 20" rather than given as the exact ratio. Rates are not reported when the total number of AIDS cases for 1996-1998 was less than 100.   

(6)

Scott D. Holmberg, "The Estimated Prevalence and Incidence of HIV in 96 Large US Metropolitan Areas," American Journal of Public Health, May 1996, vol. 86, no. 5. Supplementary Material.  Available from the CDC.  

For other materials used on this website, see References.